Empowering Your Downstream Cell and Gene Therapy Processes: A Sexton Biotechnologies Focus
BioLife Solutions acquired Sexton Biotechnologies to better serve the needs of cell and gene therapy (CGT) developers and manufacturers. Sexton complements BioLife’s existing portfolio by offering media to improve cell performance and cell expansion, automated and flexible fluid transfer manufacturing equipment, and modern CGT storage containers for closed-system processing. Sexton tools can advance your downstream […]
How to Choose the Right Freeze Media
The process of cryopreservation, which has been carried out for decades, is a crucial aspect of cell preservation for various scientific endeavors — from experimental research to clinical applications. While the fundamental process involves freezing cells and storing them at ultra-low or cryogenic temperatures, the choice of cryopreservation media plays a pivotal role in ensuring […]
The Evolution of Cell and Gene Therapy Processing Tools
01/ Borrowed tools from other industries Prior to the invention of gene therapy research, the removal, storage and reinsertion of human cell tissue was limited to blood. The logistical and technical challenges were minimal. However, scientists quickly discovered that maintaining the integrity and transparency of autologous and allogeneic cells throughout extraction, storage, transportation, delivery and […]
Sexton Biotechnologies to be Acquired by Biolife Solutions
Sexton Biotechnologies, a provider of novel manufacturing solutions for the cell and gene therapy (CGT) industry, today announced that it has entered into a definitive agreement whereby BioLife Solutions (NASDAQ: BLFS) will acquire all outstanding shares of the company in a deal worth a total value of $30 million. During the past two years, Sexton has worked to provide […]
Three Cold Chain Obstacles to Rapid COVID-19 Biologics Distribution
Journal Articles Citing CryoStor CS10® Recently Added to BioLife Solutions’ Evidence Library
Multiple Uses for CryoStor in Cell Manufacturing Journal articles recently added to BioLife Solutions’ Evidence Library illustrate several stages during the cell manufacturing process for which CryoStor CS10® cryopreservation solution is applicable. The three articles that follow include several different cell types cryopreserved in CryoStor CS10. An expanded list of cell types biopreserved in BioLife […]
Cellular Therapies for COVID-19 Highlighted During ISCT Paris 2020 (VIRTUAL)
The global impact of COVID-19 on our lives has been profound at virtually every level. Personally, professionally, politically, and economically, the pandemic impacts our lives, our relationships, and how we conduct business. We begin and end the day with the latest news on SARS-CoV-2, and up-to-the-minute COVID-19 data. In between, we must surmount any number […]
Journal Articles Citing Cryopreservation Component Recently Added to BioLife Solutions’ Evidence Library
Cryopreservation adds flexibility to timelines when working with cells. In the case of cellular therapies, that can mean initial flexibility to schedule patient cell collection, transport cells to the manufacturing facility and initiate manufacturing. Cryopreservation of the final cell therapy product adds flexibility to be able to schedule the return of cells to the patient […]
Growth Supplement Boosts CAR-T Cell Performance – Sexton Biotechnologies Releases T-Cell Specific Human Platelet Lysate
Sexton Biotechnologies today announced the launch of T-Liven-PR, a T-Cell validated Human Platelet Lysate (hPL) shown to generate highly potent CAR-T Cells. T-Liven-PR, a pooled hPL treated with pathogen reduction technology, is released against a T-cell growth performance assay and has been shown to significantly increase the percentage of T cells with naïve (TN) and […]
Sexton Biotechnologies raises $5M to accelerate commercialization of Cook Regentec’s bioproduction tools
Growth capital supports current, future innovative product development and commercialization Sexton Biotechnologies announced today that it has raised $5 million in growth capital and is the first company incubated by Indianapolis-based Cook Regentec to secure outside investment capital and spin out as an independent biotechnology company. In addition to ongoing research and product development, Sexton […]